GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?
- 4 July 1989
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 166 (1), 95-99
- https://doi.org/10.1016/0014-2999(89)90687-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phaclofen: a peripheral and central baclofen antagonistBrain Research, 1987
- Effects of carbamazepine and valproic acid on brain immunoreactive somatostatin and γ-aminobutyric acid in amygdaloid-kindled ratsEuropean Journal of Pharmacology, 1986
- [3H](−)Baclofen: an improved ligand for GABAB sitesNeuropharmacology, 1985
- Plasma GABA: A possible indicator of altered GABA function in psychiatric illnessNeuropharmacology, 1984
- Effect of Baclofen Enantiomorphs on the SpinalPharmacology, 1983
- Brain gabaergic and dopaminergic systems following lithium treatment and withdrawalProgress in Neuro-Psychopharmacology, 1981
- Lithium Increases Serotonin Release and Decreases Serotonin Receptors in the HippocampusScience, 1981
- Regional Alterations in Rat Brain Neurotransmitter Systems Following Chronic Lithium TreatmentJournal of Neurochemistry, 1980
- Evidence for two types of binding of 3HGABA and 3Hmuccimol in rat cerebral cortex and cerebelumLife Sciences, 1979
- Lithium in psychiatric therapy and prophylaxisJournal of Psychiatric Research, 1968